Rheumatoid arthritis — MCCQE Part 1 MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: D — Refer early to rheumatology and start disease-modifying treatment pathway
Refer early to rheumatology and start disease-modifying treatment pathway is best because symmetric inflammatory small-joint arthritis suggests RA. Treat with topical therapy only despite systemic or red-flag features is suboptimal because local treatment alone is inadequate when systemic disease is possible; Delay assessment for several months is suboptimal because red-flag musculoskeletal or dermatologic presentations require timely assessment; Use antibiotics for every presentation is suboptimal because many rashes and painful joints are inflammatory, malignant or mechanical rather than bacterial; Provide opioids or reassurance as the sole management is suboptimal because symptom relief alone does not address diagnosis, function or safety. Early DMARDs prevent erosive damage.
Reference: Canadian Rheumatology Association RA guidance